Form 4 for LSTA LISATA THERAPEUTICS, INC.
Accepted 2023-01-17 00:00:00 ET · period of report 2023-01-13 · accession 0001334549-23-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-17 | 2023-01-13 | LSTA | Mazzo David J | CEO, Dir | F - Tax | $3.65 | -397 | 96.5K | -0.4% | -$1,449 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-13 | F | D | 397 | $3.65 | 96,543 | D | — | — | (F1) Shares withheld as payment of a tax liability on vesting of restricted stock. (F2) Includes 60,350 unvested restricted stock. |